Pfizer stock
He is about to complete the recovery journey he started from the bottom of last June 17
Its recent decline received strong support from the $50.50 barrier
And it is testing a resistance between the average 100 and 51.48 by breaching it, while reaping the momentum with a higher trading volume that increases the chances of the rise
He is about to complete the recovery journey he started from the bottom of last June 17
Its recent decline received strong support from the $50.50 barrier
And it is testing a resistance between the average 100 and 51.48 by breaching it, while reaping the momentum with a higher trading volume that increases the chances of the rise
أقدم نظرة فنية شخصية، ليست توصية للشراء أو البيع أو الاستثمار
Plan your trade and trade your plan
خطط لمتاجرتك، وتاجر بخطتك
Plan your trade and trade your plan
خطط لمتاجرتك، وتاجر بخطتك
Aviso legal
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
أقدم نظرة فنية شخصية، ليست توصية للشراء أو البيع أو الاستثمار
Plan your trade and trade your plan
خطط لمتاجرتك، وتاجر بخطتك
Plan your trade and trade your plan
خطط لمتاجرتك، وتاجر بخطتك
Aviso legal
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.